Home
    • Plans Blog Contact
    Henry Schein Inc logo

    Henry Schein Inc

    HSIC
    Last price US$89.81
    Market cap US$9.7b
    12M price change 31.97%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Patterson Companies IncPDCO Industry peer Zynex IncZYXI Industry peer Cardinal Health IncCAH Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Henry Schein Inc Overview

    Industry: Medical Distribution

    Sector: Healthcare

    Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York. Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distributi Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Henry Schein Inc into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Aug 04, 2026

    Quarterly result summary

    Net sales was $3.5B (+7% YoY); EPS was $0.82 (reported).

    Net sales $3.5B +7% YoY
    EPS $0.82 reported
    Operating income $171M +13% YoY
    Net income $86M reported

    What changed

    • Net sales +7% YoY to $3.5B; EPS reported to $0.82.
    • Operating income +13% YoY to $171M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) Aug 04, 2026 SEC filing CURRENT REPORT FILING Aug 04, 2026 SEC filing QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) May 05, 2026 SEC filing CURRENT REPORT FILING May 05, 2026 Earnings release Earnings release May 05, 2026 SEC filing THE 2025 ANNUAL 10-K REPORT Feb 24, 2026 SEC filing HENRY SCHEIN 4Q 2025 QUARTERLY 8-K Feb 24, 2026 Earnings release Earnings release Feb 24, 2026 SEC filing HENRY SCHEIN 3Q 2025 10-Q Nov 04, 2025 SEC filing HENRY SCHEIN 3Q 2025 QUARTERLY 8-K Nov 04, 2025 Earnings release Earnings release Nov 04, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 1.00/5
    Henry Schein Inc earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Distribution industry , Patterson Companies Inc , Zynex Inc , Cardinal Health Inc are companies with high ratings.

    Return on Equity

    Score 2.43/5
    Henry Schein Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Henry Schein... HSIC US$9.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 2.51/5
    Henry Schein Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Henry Schein... HSIC US$9.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Distribution industry , Patterson Companies Inc , Zynex Inc , Cardinal Health Inc are companies with high ratings.

    Leverage

    Score 2.15/5
    Henry Schein Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    Henry Schein... HSIC US$9.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Henry Schein Inc logo

    Henry Schein Inc

    US$89.81

    US$54.76

    -39.0% vs price

    US$9.7b

    1.74%

    31.97%